BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 17 filers reported holding BETTER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $357,069 | -29.8% | 330,619 | -52.7% | 0.00% | -33.3% |
| Q1 2023 | $508,903 | -44.1% | 699,042 | -14.1% | 0.00% | -40.0% |
| Q4 2022 | $911,183 | -48.2% | 813,556 | -18.6% | 0.01% | -50.0% |
| Q3 2022 | $1,760,000 | +12.8% | 1,000,000 | 0.0% | 0.01% | +11.1% |
| Q2 2022 | $1,560,000 | -31.3% | 1,000,000 | -12.8% | 0.01% | -18.2% |
| Q1 2022 | $2,272,000 | -63.8% | 1,147,400 | -15.0% | 0.01% | -64.5% |
| Q4 2021 | $6,278,000 | – | 1,350,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 973,833 | $4,528,000 | 0.68% |
| Monashee Investment Management LLC | 217,900 | $1,013,000 | 0.25% |
| Blue Water Life Science Advisors, LP | 100,000 | $465,000 | 0.14% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,350,000 | $6,278,000 | 0.03% |
| Alyeska Investment Group, L.P. | 344,170 | $1,600,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 58,100 | $270,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 124,749 | $580,000 | 0.00% |
| UBS Group AG | 2,969 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 59 | $0 | 0.00% |
| NORTHERN TRUST CORP | 16,703 | $78,000 | 0.00% |